On 2025-05-15, Rein Therapeutics Inc. (RNTX) announced earnings per share of $-0.25 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.21.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-0.22 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-15 | 2025-03-31 | $-0.21 | $-0.25 |
| 2025-04-07 | 2024-12-31 | -- | $-0.26 |
| 2024-11-14 | 2024-09-30 | $-0.25 | $-0.27 |
| 2024-08-14 | 2024-06-30 | $-0.25 | $-0.45 |
| 2024-05-15 | 2024-03-31 | -- | $-0.86 |
| 2024-04-15 | 2023-12-31 | -- | $-1.54 |
| 2023-10-13 | 2023-09-30 | -- | $-0.40 |
| 2023-08-11 | 2023-06-30 | -- | $-0.39 |
| 2023-05-08 | 2023-03-31 | -- | $-0.82 |
| 2022-11-01 | 2022-09-30 | $-1.60 | $-1.40 |
| 2022-08-15 | 2022-06-30 | $-1.80 | $-1.80 |
| 2022-05-05 | 2022-03-31 | $-1.60 | $-1.80 |
| 2022-03-28 | 2021-12-31 | -- | $-1.60 |
| 2021-11-12 | 2021-09-30 | $-1.40 | $-1.40 |
| 2021-08-11 | 2021-06-30 | $-1.40 | $-1.20 |
| 2021-05-11 | 2021-03-31 | $-1.20 | $-1.60 |
| 2021-03-24 | 2020-12-31 | $-2.20 | $-2.40 |
| 2020-11-12 | 2020-09-30 | $-2.00 | $-2.60 |
| 2020-08-05 | 2020-06-30 | $-3.20 | $-2.80 |
| 2020-05-11 | 2020-03-31 | $-4.00 | $-4.80 |
| 2020-03-30 | 2019-12-31 | -- | $-5.20 |
| 2019-11-07 | 2019-09-30 | $-4.80 | $-5.60 |
| 2019-08-06 | 2019-06-30 | $-4.60 | $-5.20 |
| 2019-05-08 | 2019-03-31 | $-9.20 | $-9.80 |
| 2019-03-29 | 2018-12-31 | -- | $-9.60 |
| 2018-11-07 | 2018-09-30 | $-11.60 | $-10.00 |
| 2018-08-07 | 2018-06-30 | $-10.40 | $-11.20 |
| 2018-05-09 | 2018-03-31 | $-9.80 | $-10.40 |
| 2018-04-02 | 2017-12-31 | -- | $-9.40 |
| 2017-11-09 | 2017-09-30 | $-7.20 | $-8.60 |
| 2017-08-10 | 2017-06-30 | $-8.60 | $-9.00 |